Stereo Biotherapeutics
PrivateLast Round
Accelerator
Jun 20, 2025
Total Funding Raised
$100,000
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Stereo Biotherapeutics operates in Healthcare & Life Sciences and is based in Montreal. Its latest recorded funding round was an Accelerator round in June 2025.
Stereo Biotherapeutics is a biotechnology company that develops miniaturized, multi-specific soluble T-cell receptor (sTCR) biologics to address antigen heterogeneity in oncology and other diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Stereo Biotherapeutics Comparables
Compare Stereo Biotherapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Engimmune Therapeutics | 84% | |
| Yellowstone Biosciences | 79% | |
| 3T Biosciences | 77% |
For institutional investors. Book with your work email.
Stereo Biotherapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Stereo Biotherapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Accelerator |
| Consortium Québécois sur la découverte du médicament | Accelerator |
| Merck Digital Sciences Studio | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 28, 2026
Monthly visitors increased 208% MoM.
- Jun 30, 2026
Grew 38% QoQ from 8 to 11 employees.
For institutional investors. Book with your work email.
Stereo Biotherapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Stereo Biotherapeutics's valuation, stock price, and market status.
Is Stereo Biotherapeutics a public or private company?
Stereo Biotherapeutics is a private company.
What is the current stock price of Stereo Biotherapeutics?
Stereo Biotherapeutics is a private company, so its shares have no public market price. Caplight tracks Stereo Biotherapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Stereo Biotherapeutics worth (valuation)?
Valuation information for Stereo Biotherapeutics is not publicly available.
Can I buy Stereo Biotherapeutics stock?
Stereo Biotherapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Stereo Biotherapeutics's last funding round?
Stereo Biotherapeutics's most recent funding round was Accelerator on June 20, 2025.
Who are the main investors in Stereo Biotherapeutics?
Key investors in Stereo Biotherapeutics include Amplitude Ventures, Consortium Québécois sur la découverte du médicament, Merck Digital Sciences Studio.
Will Stereo Biotherapeutics IPO soon?
No public IPO plans have been announced for Stereo Biotherapeutics.
How can I track Stereo Biotherapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Stereo Biotherapeutics's shares on secondary markets.